baber/WOPTO huggingface dataset:
Patent AU-PR611101-A0 (AU)
Title: Apparatus and analysis method for determination of moisture in materials
IPC: G01N22/04
Filed: 2001-07-04
Abstract: There is disclosed a method of estimating moisture content in a material involving directing a first frequency (f<SUB>1</SUB>) signal and a second frequency (f<SUB>2</SUB>) signal through a material, determining a first absolute phase shift (phi<SUB>1</SUB>) of the frequency signal and a second absolute phase shift (phi<SUB>2</SUB>) of the second frequency signal, transforming phi<SUB>1 </SUB>to a first corrected absolute phase shift (phi<SUB>1c</SUB>) and phi<SUB>2 </SUB>to a second corrected absolute phase shift (phi<SUB>2c</SUB>) in accordance with an expected relationship between phi<SUB>1 </SUB>and phi<SUB>2</SUB>, and estimating moisture content from phi<SUB>1c </SUB>and phi<SUB>2c</SUB>.
Patent ES-488034-A0 (ES)
IPC: D21H17/43
Filed: 1980-01-25
Abstract: A process for the manufacture of paper having a high dry strength and a low wet strength, by treating the surface of the paper with an aqueous solution of an alkali metal and/or alkaline earth metal salt of a polymer of (a) from 91 to 100% by weight of acrylic acid and/or methacrylic acid and (b) from 0 to 9% by weight of acrylonitrile, methacrylonitrile, acrylamide, methacrylamide, vinyl acetate, maleic anhydride, diisobutylene, an ester of acrylic acid and/or an ester of methacrylic acid, which has a viscosity of from 5 to 100 mPas in 2% strength aqueous solution at 20 DEG  C., and drying the impregnated paper. The polymer is generally employed in an amount of from 1 to 4% by weight, based on dry paper, and increases the dry strength of the paper without substantially increasing the wet strength.
Patent FI-20011277-A0 (FI)
Inventor: KOSKIMIES OSKARI
IPC: G06F12/00
Filed: 2001-06-15
Abstract: A method for selecting a data set to be synchronized from databases of a data system, in which system metadata illustrating the relationships between data units of the data system are stored for the selection of the data set to be synchronized. The metadata comprises at least information on the relevance between the data units. When a first data set is to be synchronized, metadata associated with at least one initial data unit of the first data set is retrieved. Next, a second data set, which according to at least one metadata element comprises a data unit of maximum relevance to the initial data unit, is selected for synchronization.
Patent FI-20065334-A0 (FI)
Inventor: NIVA ARTO
IPC: A61B/
Filed: 2006-05-18
Abstract: In the solution of the invention, an association is formed (702) between activity information characterizing the activity level of a user and a performance parameter value proportional to the heart rate information of the user, the activity information and heart rate information having been measured in a user-specific performance monitor, and the heart rate information being responsive to the activity level.
Patent FI-20115531-A0 (FI)
Inventor: TAKANIEMI TAUNO
IPC: B65H/
Filed: 2011-05-27
Abstract: A device for feeding a tape (T) between two cardboard webs (W1, W2) comprises a transfer means (3) placed in a narrowing gap between the cardboard webs (W1, W2) and comprising one or more mounting points for an end of a tape (T). The transfer means is arranged to be swivelled around a rotation axis (A) in a guiding boom (1 ) for the tapes, and to be swiveled towards one of the two cardboard webs (W1) delimiting the gap, for pressing and fastening the gripping end (T1 ) of the tape equipped with an adhesive piece to the cardboard web (W1 ).
Patent IL-104599-A0 (IL)
Title: Reversal of multi-drug resistance by tetraarylethylenes
IPC: A61K31/445
Filed: 1993-02-03
Abstract: Certain tetraarylethylenes reverse drug resistance in multi-drug resistant tumors. These compounds apparently function by inhibiting a p-glycoprotein pump which becomes activated in late stage tumor development and which is inherently present in tumors from certain origins.
Patent IL-106896-A0 (IL)
Title: Soluble ligands for cd40
IPC: C07K14/00
Filed: 1993-09-03
Abstract: The present invention relates to soluble ligands for the B-cell antigen, CD40, and, in particular, to human gp39 protein and soluble ligands derived therefrom which may be used in methods of promoting B-cell proliferation.
Patent IL-109259-A0 (IL)
Title: Novel polypeptide having factor Xa inhibitory activity
IPC: C12R1/19
Filed: 1994-04-08
Abstract: A novel polypeptide derived from the leech Hirudo medicinalis was found to be able to inhibit Factor Xa thereby reducing the extent of blood coagulation. The polypeptide is useful in treating conditions of excessive blood coagulation. A recombinant organism containing cDNA encoding the polypeptide has been deposited in the ATCC under Accession No. 69134. Recombinant microorganisms able to produce the polypeptide have been deposited in the ATCC under Accession Nos. 69135, 69137 and 69269.
Patent IL-112497-A0 (IL)
Title: Drug
IPC: A61K9/70
Filed: 1995-01-31
Abstract: A pharmaceutical formulation contg. at least one neutral or carboxylic acidic active ingredient with a dissociation constant below 10<-3>, mol. wt. below 500 and the following solubilities at room temp. (a) < 1% in water, (b) > 10% in 70% ethanol, (c) > 35% in CHCl3, (d) > 60% in pyridine comprises a transdermal therapeutic system contg. the active ingredient(s) in a galenic formulation which can take up sweat and from which the active ingredient(s) is/are constantly released over at least 24 hrs. by the action of the sweat water. Pref. the galenic formulation consists of 10-30 wt.% 5,6-benzo- alpha -pyron, 1-50 wt.% of a cremophor, 15-85 wt.% one or more polyalkylene glycols and opt. other emulsifiers, aids to consistency, aids to dissolution, solvents and/or higher 8-24C fatty alcohols.
Patent IL-115491-A0 (IL)
Title: Wrap-around carrier
IPC: B65D5/50
Filed: 1995-10-02
Abstract: A wrap-around carrier having improved secondary locking means. A secondary locking tab contains a retaining opening, and one edge of a secondary locking opening includes a retaining tab which fits into the retaining opening to prevent withdrawal of the locking tab. A retaining flap engaging the secondary locking tab prevents the locking tab from moving out of engagement with the retaining tab.
Patent IL-115917-A0 (IL)
Title: Novel complexes and their compositions
IPC: C07D305/14
Filed: 1995-11-08
Abstract: This invention provides inclusion complexes of Taxol ((2aR-(aalpha,4beta,4alphabeta,6beta,9alpha(alphaR*,betaS*),11alpha,12alpha,12aalpha,12balpha))-beta-(benzoylamino)-alpha-hydroxy-benzene-propanoic acid 6,12-b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclo-deca-(3,4)-benz-(1,2-b)-oxeth-9-yl-ester)) or Taxotere (butoxycarbonyl-10-desacetyl-N-debenzoyl-Taxol) or Taxus extracts formed with a cyclodextrin derivative and a co-solvent. This invention relates to pharmaceutical composition with increased water-solubility and stability. This invention provides the process for the preparation of an inclusion complex of Taxol or Taxotere or a brevifolia extract of Taxus formed with a cyclodextrin derivative and a co-solvent. This invention relates to pharmaceutical composition, containing as active ingredient an effective amount of an inclusion complex of Taxol or Taxotere or a Taxus brevifolia extract formed with a cyclodextrin derivative, preferably heptakis-2,6-0 dimethyl-beta-cyclodextrin, random methylated beta-cyclodextrin, succinylmethyl-beta-cyclodextrin and a co-solvent together with usual filling, diluting and other auxiliaries generally used in the pharmaceutical industry.
Patent IL-118356-A0 (IL)
Title: Method of administration of IGF-I
IPC: A61P9/00
Filed: 1996-05-22
Abstract: A method is disclosed that comprises administering insulin-like growth factor-I (IGF-I) to a mammal so as to sustain its biological activity in the mammal comprising administering a therapeutically effective amount of IGF-I to the mammal to provide an exposure to IGF-I for a period of time that stimulates the maximum biological response in the mammal, then discontinuing said administration for a period of time equal to or less than the time period used for administration, and repeating this pattern of administration and discontinuance of administration for a period as long as necessary to achieve or maintain the desired biological response in the mammal.
Patent IL-134239-A0 (IL)
Title: Hitch assembly and trailer
IPC: B60D1/42
Filed: 1998-07-14
Abstract: A hitch and trailer assembly includes a trailer having a mounting member and a hitch receiver mountable to a motor vehicle for receiving the mounting member. The hitch and trailer assembly also include a plurality of rollers for connection to one of the trailer and the motor vehicle and a plurality of bumpers for connection to the other one of the trailer and the motor vehicle to allow the rollers and the bumpers abut each other when the mounting member is disposed in the hitch receiver.
Patent IL-139356-A0 (IL)
Title: Apparatus for locating a plurality of articles
IPC: G01N35/00
Filed: 1999-05-04
Abstract: An apparatus for locating a plurality of articles for laser marking comprising a support plate (16) having a plurality of apertures (18) extending from a first surface of the plate (15) to a second surface of the plate (17). The apertures are dimensioned to receive said articles (12) at the first surface of the plate (15), so that the at least a portion of the article is exposed through the aperture (18). Preferably apertures are defined by tapering walls.In use a laser (30) is directed towards a protruding portion of the article (21). The extent to which the articles protrude through the aperture (18) is significantly less than the variation in diameter of articles (12) to be laser marked. This eliminates the need for the laser to focus on individual articles (12).
Patent IL-151527-A0 (IL)
Title: Mutated cyclyn g1 protein
IPC: A61P9/00
Filed: 2001-03-01
Abstract: Methods of treating tumors, preventing restenosis, and treating hyperplasias, corneal haze, and cataracts by administering to an animal a mutated cyclin G1 protein. The mutated cyclin G1 protein may be administered to an animal by administering to an animal an expression vehicle, such as a retroviral vector comprising a gene construct encoding a mutated cyclin G1 protein.
Patent IL-153504-A0 (IL)
Title: Methods and compositions for amplification of rna sequences
IPC: C12Q1/68
Filed: 2002-03-11
Abstract: The invention provides methods for isothermal amplification of RNA. The methods are particularly suitable for amplifying a plurality of RNA species in a sample. The methods employ a composite primer, a second primer and strand displacement to generate multiple copies of DNA products comprising sequences complementary to an RNA sequence of interest. In another aspect, the methods employ a single primer (which is a composite primer) and strand displacement to generate multiple copies of DNA products comprising sequences complementary to an RNA sequence of interest. In some embodiments, a transcription step is included to generate multiple copies of sense RNA of an RNA sequence of interest. The methods are useful for preparation of nucleic acid libraries and substrates for analysis of gene expression of cells in biological samples. The invention also provides compositions and kits for practicing the amplification methods, as well as methods which use the amplification products.
Patent IL-154417-A0 (IL)
Title: Preparation of risperidone
IPC: C07D471/04
Filed: 2001-08-14
Abstract: The present invention is directed to the novel forms of risperidone, designated Form A, Fomi B and Fonn E. Methods for their preparation are also disclosed. The present invention also relates to processes for making risperidone. Pharmaceutical compositions containing the new forms of zisperidone and methods of using them are also disclosed.
Patent IL-179028-A0 (IL)
Title: Piperazine derivatives of alkyl oxindoles
IPC: A61P25/00
Filed: 2006-11-02
Abstract: The present invention is concerned with new indol-2-one derivatives of Formula (I), which have favorable activity profile for the prophylaxis and treatment of disorders in the central nervous or in the cadiovascular system.
Patent RO-133481-A0 (RO)
Title: Fitness apparatus gn
Inventor: NICULESCU GEORGE
IPC: A63B23/12
Filed: 2019-02-26
Abstract: The invention relates to a fitness apparatus. According to the invention, the apparatus consists of an upper framework (2) provided with a chainring (3) and some pinions (8) which, together with a chain (7) and a speed-change gear (11) provided with a lever (12) make a kinematic system forming a gear box, a chainring axle (5) being provided with a chainring pulley (4) making the connection with a spring (15) by means of a traction cable (6), a hub (10) provided with a pulley (9) making the connection with a traction grip (14), by means of a traction cable (13), and a lower framework (16) which consists of a top plate (17) provided with two traction and attachment hooks (18 and 19) and some guiding rods (20) on which the top plate (17) slides, joined at the bottom by a lower plate (21) and at the top by a fixed plate (22).
Patent RO-133601-A0 (RO)
Title: Device with silicone brush for toilet bowl cleaning
Inventor: GUŢIU EUGEN
IPC: A47K11/10
Filed: 2019-04-04
Abstract: The invention relates to a device with silicone brush meant for cleaning the toilet bowl. According to the invention, the device has a disinfection system (10) and a system for activating the cleaning process via a sensor (8), a toilet bowl washing brush (5) with a handle (4), which is placed in a bowl (6) within a body (1) that supports the entire device , the brush (5) being made of silicone and being intended to operate with 4, 5 or 6 blades of conical helical shape, allowing it to fit tight and have good contact allover the toilet bowl surface, and having at its bottom a magnet (9) which actuates the sensor (8) as to detect the position of the brush (5) in the bowl (6) and activate the cleaning process, a disinfecting liquid (16) being taken from a container (11) and pumped through a hose (14) into an upper lid (3) which has internal channels and orifices for the liquid distribution and a submersible pump (13) located in the liquid container (11) covered by an intermediate lid (12) pumping the cleaning liquid and distributing it through the upper lid (3), as to reach the surface of the silicone spiral (5) and form an anti-adhering film thereon, in order to prevent residues from sticking thereto during the utilization of the brush (5) and to disinfect it, where, after the liquid pumping and the primary disinfection of the brush (5), it is subjected to a secondary disinfection with UV light produced by a set of UV LEDs (7) which are placed in the bowl (6) and controlled by an electronic board embedded in a subassembly (15) which also contains a detachable storage battery, while some multicolour LEDs (2) embedded in the body (1) inform the user about the device state regarding the storage battery charging level, the cleaning liquid (16) level as well as the cleaning cycle start and finish moments.
Patent RO-137737-A0 (RO)
Title: Steam injection plant in a spiral-type industrial oven for bread or pastry products, fed with dough pieces by its bottom side
Inventor: MUSCALU GHEORGHE
IPC: A21B1/22
Filed: 2023-07-05
Abstract: The invention relates to a steam plant in a spiral-like industrial oven for bread or pastry products, which is fed with the dough pieces by its bottom side. According to the invention, the plant increases humidity in a spiral-like bread oven (1) fed with the dough pieces by its bottom side, by using low pressure steam of maximum 0.42 bar as a steam curtain at the stages 1, 2 and 3 and as a jet at stages 5 and 7, and it consists of a thermally-insulated vertical distributor (4) mounted inside or outside the oven (1), with the role of vertically distributing steam on the stages 1, 2, 3, 5 and 7, and 3 horizontal distributors (7) mounted outside area 1 which is insulated both from area 2 and from the inside of an oven (22) with refractory stainless steel sheet, with the role of injecting steam on a certain surface of each stage, 15 pipes (6) with 9 nozzles (8) each, wherethrough the steam injection is performed directly onto the surface of some dough pieces (12) passing below some nozzles (8) and a condensation water draining system (11) which is meant to enable the steam flowing through the pipes unobturated.
Patent IE-910651-A1 (IE)
Title: Benzofurans
IPC: A61P35/00
Filed: 1991-02-26
Abstract: Compounds are disclosed of the formula I  in which X denotes, for example, halogen, cyano, carbamoyl or aryloxy and also represents other substituents which have the meaning given in the description, Y represents a group -CH2-A in which A denotes imidazolyl, triazolyl or tetrazolyl bonded via a ring nitrogen atom, R1 and R2 independently of one another denote hydrogen, lower alkyl or a group -CH2-A as defined for Y, or Y, R1 and R2 independently of one another assume meanings which are described in the application. These compounds have useful pharmaceutical properties and are particularly active as inhibitors of the enzyme aromatase and against tumours. They are prepared in a known manner.
Patent MA-24667-A1 (MA)
Title: Centrale clignotante electronique ou relais clignotant electronique ou lignotant telectronique
IPC: G08G1/09
Filed: 1998-08-28
Abstract: C'EST UN RALLONGE QUI A DEUX DEUX PRISES CLIGNOTANTS LORSQUE LE 1ER PRISE AC  CONDUIT LE COURANT ( ALLUMAGE DE LA LAMPE)  LE 2èME PRISE AC SE BLOQUE (LAMPE ÉTEINTE)  ET LORSQUE LE 2èME PRISE AC CONDUIT LE COURANT LE 1ER PRISE AC SE BLOQUE. CE PHÉNOMèNE EST PÉRIODIQUE ET PEUT RESTER UNE DURÉE INFINIE. LA FRÉQUENCE DE CES CLIGNOTEMENT EST RÉGLABLE EN FAISANT VARIER LA RÉSISTANCE DU POTENTIOMèTRE DE RÉGLAGE PAR UN TOURNEVIS.CE RALLONGE POSSèDE AUSSI UN OU PLUSIEURS PRISES NORMALES.LA TENSION DE FONCTIONNEMENT PEUT-eTRE  12V,   24V,  1OOV  OU 22OV.LA PUISSANCE MAXIMALE ADMISSIBLE DES RÉCEPTEURS PEUT-eTRE JUSQU'à 26OOV. CE CLIGNOTANT PEUT eTRE AUSSI UTILISÉ DANS L'INDUSTRIE COMME UN RELAIS QUI S'OUVRE ET SE FERME PÉRIODIQUEMENTET DONT LA PÉRIODE EST RÉGLABLE PAR UN POTENSIOMèTRE. ET ON PEUT AJOUTER DES LAMPES TÉMOINS QUI NOUS INFORMENT SUR LA FERMETURE OU L'OUVERTURE DU RELAIS.
Patent MA-39331-A1 (MA)
Title: Système naturel de collecte des déchets jetés dans la nature et les espaces publiques
Inventor: MOUMEN YOUNES
IPC: B65F1/00
Filed: 2016-09-05
Abstract: Un système mettant à contribution des animaux, et particulièrement des oiseaux et des poubelles adaptées pour la collecte des déchets présents dans la nature et les espaces publiques. Les animaux sont dressés pour récupérer des déchets et les jeter dans les poubelles. Celles-ci sont équipées d'un perchoir et d'une plateforme pour accueillir l'animal, d'une trappe pour jeter les ordures et d'un compartiment à nourriture.
Patent MA-52107-A1 (MA)
Title: Compositions et procédés pour l'atténuation d'une infestation par le ravageur rhynchophorus ferrugineus
Inventor: SHALITIN DROR
IPC: A01N37/46
Filed: 2019-07-17
Abstract: La présente invention concerne de l'arndb pour la prévention, l'atténuation et/ou le traitement d'une infestation d'une plante par le charançon rouge du palmier (rhynchophorus ferrugineus), l'arndb comprenant une séquence polynucléotidique qui est environ 85 % à environ 100 % complémentaire à un segment d'un gène cible du charançon rouge du palmier, l'ingestion du polynucléotide arndb par le charançon rouge du palmier entraînant la mortalité et/ou l'étourdissement de celui-ci.
Patent UY-23446-A1 (UY)
Title: Dispositivo de identificación y localización de vehiculos
IPC: B60Q9/00
Filed: 1992-07-13
Abstract: La presente invención es capaz de establecer de manera visual la situación de vehículos integrados al sistema, para determinar si amerita su ubicación aun en movimiento, posible mediante medios conectados entre si, caracterizado por ser un conjunto de transceptores ubicados en vehículos que conforman una red de emisión de señales u ondas de radio-frecuencia y operan dentro de una determinada gama de frecuencia con señales codificadas; vinculables a un conjunto de estaciones receptores conectadas a un ordenador programado para visualizar las mismas e identificarlas por medio de una tarjeta/decodificador establecimiento la situación de cada vehículo y maximizarlas; datos inmediatamente diligenciados por estaciones fijas y móviles de triangulado entre si y con medios de barrido (radares) que se van sustituyendo por otras mas cercanas, hasta llegar al rodado (y brindarle auxilio).
Patent UY-24653-A1 (UY)
Title: Nuevos compuestos
Inventor: HUNT ERIC
IPC: C07C311/08
Filed: 1997-07-31
Abstract: Procedimiento para preparar: un compuestos de fórmula (3) (ver figura 1) y las sales o derivados farmacéuticamente aceptables de los mismos en la que R1 es vinilo o etilo; R3 y R4 es un sistema de anillo azabicíclico o R5 y R6, junto al átomo de carbono al que se encuentran unidos, forman un sistema de anillo azabicíclico. El procedimiento se caracteriza por hacer reaccionar un compuesto de los representados en la figura 2, con un isocianato de acilo. El anillo azabicíclico es por ejemplo seleccionado entre azabiciclo[2.2.2]octilo, azabiciclo[2.2.1]heptilo, azabiciclo[3.2.1]octilo, entre otros. Ejemplo no limitante: 14 éster de mutilina del ácido (1-aza-biciclo-[2.2.2]octano-4-carbonil)carbámico. Estos compuestos son útiles en la prevención y tratamiento de infecciones microbianas.
Patent UY-26502-A1 (UY)
Title: Oxazolidinonas substituidas y su uso
Inventor: STRAUB DR ALEXANDER
Filed: 2000-12-22
Abstract: La invención se refiere al campo de la coagulación sanguínea. Se describen nuevos derivados de oxazolidinona de fórmula general (I) procedimiento para su preparación así como principio activo en medicamentos para la profilaxis y/o tratamiento de enfermedades.
Patent UY-26900-A1 (UY)
Title: Heterociclos bicíclicos, medicamentos que contienen estos compuestos, su empleo y procedimientos para su preparación
Inventor: HIMMELSBACH DR FRANK
Filed: 2001-08-23
Abstract: La presente invención se refiere a heterociclos bicíclicos de la fórmula general (I) en la que Ra a Rc´ A a E y X están definidos como en la reivindicación 1, a sus tautómeros, sus estereoisómeros y sus sales, en particular sus sales fisiológicamente compatibles con ácidos o bases inorgánicos u orgánicos, que presentan valiosas propiedades farmacológicas, en particular un efecto inhibidor sobre la transducción de senales inducida por tirosino-quinasas, a su empleo para el tratamiento de enfermedades, en particular de enfermedades tumorales, de enfermedades de los pulmones y de las vías respiratorias, y a su preparación.
Patent UY-27993-A1 (UY)
Title: Derivados de 4-pirrolidino-fenil-bencil eter
Inventor: JOLIDON SYNESE
IPC: C07D207/277
Filed: 2003-09-19
Abstract: Derivados 4-pirrolidino racémica o enantioméricamente puros, procesos para su preparación, composiciones farmacéuticas que comprenden dichos derivados, y su uso en la prevención y tratamiento de enfermedades, por ejemplo que están mediadas por inhibidores de monoamino oxidas B, en particular enfermedad de Alzheimer o demencia senil.
Patent UY-29339-A1 (UY)
Title: Derivados de triazol sustituidos como antagonistas de oxitocina
Inventor: BROWN ALAN DANIEL
IPC: C07D211/36
Filed: 2006-01-18
Abstract: La presente invención se refiere a triazoles sustituidos de fórmula (I), a sus usos, a procedimientos para su preparación y a composiciones que contienen dichos compuestos. Estos inhibidores tienen utilidad en diversas áreas terapéuticas incluyendo disfunción sexual